Correspondence 0001493152-24-044633 from Glucotrack, Inc. (GCTK)
Glucotrack, Inc.
Date: Nov. 12, 2024 · CIK: 0001506983 · Accession: 0001493152-24-044633
AI Filing Summary & Sentiment
File numbers found in text: 333-282158
Show Raw Text
CORRESP 1 filename1.htm DAWSON JAMES SECURITIES INC. 101 North Federal Highway Suite 600 Boca Raton, Fl 33432 November 12, 2024 VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549-3628 Attn: Mr. Juan Grana RE: Glucotrack, Inc. (the “Company”) Registration Statement on Form S-1 (File No. 333-282158) (the “Registration Statement”) Dear Mr. Grana: Dawson James Securities Inc., the placement agent in the offering contemplated in the Registration Statement, hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 4:30 P.M. Eastern Time on Tuesday, November 12, 2024, or as soon thereafter as practicable. Once the Registration Statement has been declared effective, please orally confirm that event with Howard Hirsch of Nelson Mullins Riley & Scarborough LLP, counsel to the Company, at (404) 322-6226. Very truly yours, DAWSON JAMES SECURITIES INC. By: /s/ Robert D. Keyser, Jr. Name: Robert D. Keyser, Jr. Title: Chief Executive Officer